Markets open

CVS Health Corporation

CVS · NYSE

Analyst Consensus

Buy

23 analysts

$98

Current

—

Low

$114

Average

—

High

Average target implies +16.05% versus the current price.

The ratings synthesis for CVS has not been generated yet.

Rating Actions

No individual rating actions have been captured for CVSyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

B OF A GLBL RES

BARCLAYS CAPITA

CANTOR FITZGERA

CO FORECST

DEUTSCHE BK SEC

EDWARD JONES

EVERCORE ISI

GOLDMAN SACHS

HSBC GLOBAL RES

JEFFERIES & CO.

JP MORGAN SECUR

MIZUHO SECURITI

MORGAN STANLEY

OPPENHEIMER HLD

PIPER SANDLER

RAYMOND JAMES

RBC CAPITAL

SANFORD BERNSTE

TD COWEN

TRUIST SECURITI

UBS

WELLS FARGO SEC

WOLFE RESEARCH

Symbol: CVS
Type: Stock
Sector: Consumer Staples
Industry: Retail-Drug Stores and Proprietary Stores
Country: North America
Exchange: NYSE

CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 88 million plan members. The Company also serves an estimated more than 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Analyst Consensus

See all

Buy

23 analysts

$98

Current

—

Low

$114

Average

—

High

Average target implies +16.05% versus the current price.

Earnings History

BeatMissNo estimate

CVS Health Corporation

Analyst Consensus

Rating Actions

Covering Firms

Peers